Scholar Rock — SMA muscle drug (apitegromab)
Sector: health
Conviction from: NASDAQ
52-week range: 36.7761.76
2 tracked filer(s) hold this · 0 opened, 1 added, 1 trimmed in 30-SEP-2026
Aggregate 13FScore 68 — mean of 2 scored holder(s) · buyers (new/add) avg 75. Higher = the smart money in this name has the better track record.
Beyond 13F — activists, insiders, politicians & research
| Filed | Insider | Role | Shares | Value | |
|---|
| 2026-10-27 | AKKARAJU SRINIVAS | director | 289,470 | $11,999,922 | Form 4 |
| Report | Date | Stance |
|---|
| #102 — GLP-1s: The Second Serving - Revisiting our GLP-1 Basket | 2025-07-24 | WATCH |